# Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

> **NCT00643500** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 342 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00643500
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643500, "Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00643500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*